Background:
PatientMetRx®, a solution from pioneering data tech company Talking Medicines specializing in data science and using its proprietary Drug-GPT™ across its suite of capabilities. They are the forefront of utilizing Conference topic tracking along with its unique proprietary index, known as Individual Indicator Index (III™). Used to evaluate the effectiveness of pharmaceutical companies’ strategies in engaging Healthcare Professionals (HCPs), Digital Opinion Leaders (DOLs), and Key Opinion Leaders (KOLs) pre/post/during Medical Conferences. This blog sheds light on how PatientMetRx® assists pharmaceutical clients in optimizing their influencer-driven campaigns.
The Challenge:
Pharmaceutical companies and their Agencies frequently collaborate with HCPs, DOLs, and KOLs to promote their products and innovations at Medical Conferences.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.